Catalyst Capital Advisors’s Insulet PODD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-453
Closed -$142K 477
2025
Q2
$142K Buy
+453
New +$131K ﹤0.01% 282
2025
Q1
Sell
-363
Closed -$94.8K 518
2024
Q4
$94.8K Buy
+363
New +$91.4K ﹤0.01% 303
2020
Q1
Sell
-7,400
Closed -$1.27M 307
2019
Q4
$1.27M Buy
+7,400
New +$1.23M 0.04% 124
2016
Q1
Sell
-6,500
Closed -$246K 600
2015
Q4
$246K Sell
6,500
-500
-7% -$16.8K 0.04% 234
2015
Q3
$181K Sell
7,000
-40,000
-85% -$1.21M 0.02% 284
2015
Q2
$1.46M Buy
+47,000
New +$1.39M 0.17% 130

Other funds holding PODD

Catalyst Capital Advisors's PODD Position: Q3 2025 in Review

Catalyst Capital Advisors sold out of Insulet (PODD) in Q3 2025, closing a stake of 453 shares — an estimated $142K sold.

Catalyst Capital Advisors first reported a position in PODD in Q2 2015 and held it in 6 quarters. The position peaked at $1.46M in Q2 2015. 813 funds tracked by Wall St. Rank hold PODD as of Q3 2025.

  • Catalyst Capital Advisors reported no remaining Insulet position as of Q3 2025 after selling out during the quarter.
  • Catalyst Capital Advisors sold 453 Insulet shares in Q3 2025, an estimated $142K.
  • Catalyst Capital Advisors first reported a position in Insulet in Q2 2015 and held it in 6 quarters.
  • Catalyst Capital Advisors's Insulet position peaked at $1.46M in Q2 2015.
  • 813 funds tracked by Wall St. Rank held Insulet as of Q3 2025.

Based on Catalyst Capital Advisors's 13F filing for Q3 2025, filed 12 Nov 2025.